Literature DB >> 1690914

CD5 mRNA expression and auto-antibody production in early human B cells immortalized by EBV.

T Paavonen1, R Quartey-Papafio, P J Delves, L Mackenzie, T Lund, P Youinou, P M Lydyard.   

Abstract

A number of studies have suggested that lymphocytes producing polyreactive antibodies belong to the CD5+ B-cell subset. In this study we have examined CD5 at the cell surface and mRNA levels in EBV-driven cord blood and fetal liver clones previously characterized in terms of their antibody specificities. We show that EBV-immortalized cells can express surface CD5, and that some of the clones not expressing surface CD5 express it at the mRNA level. The complete absence of CD5 mRNA in some polyreactive clones is consistent with the proposition that the production of auto-antibodies and multispecific antibodies is not restricted to the CD5+ B-cell subset.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690914     DOI: 10.1111/j.1365-3083.1990.tb02768.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.

Authors:  D Kaplan; D Smith; H Meyerson; N Pecora; K Lewandowska
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

2.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

3.  Common idiotypes expressed on human, monoclonal, abnormal immunoglobulins and cryoglobulins with polyreactive autoantibody activities.

Authors:  M R Barbouche; B Guilbert; S Makni; Y Gorgi; K Ayed; S Avrameas
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

4.  Human B-cell ontogeny in humanized NOD/SCID γc(null) mice generates a diverse yet auto/poly- and HIV-1-reactive antibody repertoire.

Authors:  H Chang; S Biswas; A S Tallarico; P T N Sarkis; S Geng; M M Panditrao; Q Zhu; W A Marasco
Journal:  Genes Immun       Date:  2012-05-17       Impact factor: 2.676

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.